• Content (Accesskey 0)
  • Navigation (Accesskey 1)
  • About us
  • Events
  • How to contact us
  • What's new
  • Accessibility
  • Legal notice
  • Privacy notice
DeutschEnglish
BASG
menu
  • Market Surveillance
    Official announcements
    • Messages in brief
    • Human medicines
    • Veterinary medicines
    • Blood & tissue
    • Medical devices
    • Illegal market
    Public registers
    • Certified SARS-CoV-2 antigen rapid tests
    • Medicine shortages catalogue open_in_new
    • Catalogue according to the regulation on ensuring the provision of medicinal products open_in_new
    • Austrian Medicinal Product Index open_in_new
    • Pharmaceutical companies
    • Register of retailers
    • Internet pharmacies open_in_new
    • Non-interventional studies open_in_new
    • BASG official announcement open_in_new
    • BASG voting results open_in_new
    Reporting
    • Human adverse reaction notification
    • Veterinary Adverse Event Reports
    • Quality defects
    • Medicine shortages
    • Illegal occurrences
    • Medical devices vigilance
    • Haemovigilance
    • Tissue vigilance
    • MedSafety Week 2020
  • For Consumers
    Facts worth knowing about medicines
    • Medicinal products
    • Vaccines
    • Administration of medicines
    • Package leaflet
    • Prescription/Non-prescription requirements
    • Ability to drive
    • Medication allergies
    • Doping
    • Expiry date and storage of medicines
    • Disposal of medicinal products
    • Useful Links
    Clinical Trials
    • Clinical studies and the war in Ukraine
    • EUPATI
    • Austrian information center regarding clinical trials for cancer therapy
    Medicines from the Internet
    • Online medicine retailers
    • Illegal websites
    Illegal market
    • Enforcement
    • Falsified medicines
    • "Predatory publishers" and their effect
    • Glossary
    Medical devices
  • For Healthcare Professionals
    Safety information (DHPC)
    Clinical trials
    • Clinical trials and the war in Ukraine
    • Clinical studies and COVID-19
    • Clinial trials with medicinal products
    • Good Clinical Practice
    • Non-Interventional-Studies NIS
    • Compassionate use/Named Patient Use
    • Clinical investigations with medical devices
    Blood safety
    • Authorisation and inspection of blood establishments
    Tissue safety
    • Certification, authorisation, and inspection of tissue establishments
    Medical Device Operators
    • FAQ's medical device operators
    Bringing into circulation
    • Supply of drugs for COVID-19 therapy
    • Dispensing of veterinary antibiotics
    • Internet pharmacy
    • Self-assessment of pharmacies
    • Sampling
    Austrian Pharmacopoeia
    • Draft monographs for comments
    • Archive of monographs
    • Archive of deleted monographs
    CHMP Meeting Highlights-BASG
    • The CHMP introduces itself
  • For Companies
    Online services
    • Login online services open_in_new
    • Login Vigiweb open_in_new
    • Reporting adverse reactions open_in_new
    • Login NIS open_in_new
    • Registration online services open_in_new
    • Contact
    • Veterinary Antimicrobial Consumption
    • Data provision medicine shortages
    • Data provision Falsified Medicines Directive
    • FAQ online Service
    • PHAROS user group
    • Instructions for use
    Marketing authorisation & life-cycle
    • Marketing authorisation procedure
    • Austria as RMS
    • Electronic application
    • AGES eValidator
    • FAQ electronic Submission
    • Life-Cycle
    • Commission decisions
    • Forms for medicinal products
    • Change of ownership acc. to Art 25 AMG
    • Veterinary medicinal products
    • FAQ marketing authorisation & life-cycle
    Pharmacovigilance
    • Pharmacovigilance inspection
    • PHV-wordings
    • Submission of Periodic Safety Update Reports (PSURs)
    • FAQ pharmacovigilance
    • Guideline pharmacovigilance
    Medicinal products
    • Scientific advice by BASG
    • Quality of medicines
    • Medicines for children
    • Plasma derived products
    • Batch release
    • Recombinant proteins
    • Addictive drugs
    • Radiopharmaceuticals
    Import and export of medicines
    • Import of medicines
    • FAQ Import of medicinal products
    • Certificate for a Pharmaceutical Product (CPP)
    Medical devices
    • COVID 19
    • Manufacturer
    • Importer
    • Medical devices fee
    • Free Sale Certificate - (FSC)
    • MDR / IVDR
    Authorisation and certification
    • GMP/ GDP
    • Good Laboratory Practice (GLP)
    • IT inspections
    Borderline products
    • Decisions of the AGBR
  1. Home
  2. For Companies
  3. Marketing authorisation & life-cycle
  4. Veterinary medicinal products
  • Marketing authorisation & life-cycle
  • Marketing authorisation procedure
  • Austria as RMS
  • Electronic application
  • AGES eValidator
  • FAQ electronic Submission
  • Life-Cycle
  • Commission decisions
  • Forms for medicinal products
  • Change of ownership acc. to Art 25 AMG
  • Veterinary medicinal products
    • Austria as RMS open_in_new
    • The new EU veterinary medicinal products regulation
    • Antimicrobial Consumption open_in_new
    • Contact
  • FAQ marketing authorisation & life-cycle

Veterinary medicinal products

  • Austria as RMS
  • The new EU veterinary medicinal products regulation
  • Antimicrobial Consumption
  • Contact
Email

Further inquiry note

basg-heve@basg.gv.at
Page last modified: 21/04/2022

For Companies

  • Marketing authorisation & Life-Cycle
  • Medical devices
  • Pharmacovigilance

Market Surveillance

  • Medicine shortage
  • Quality defects

For Healthcare Professionals

  • Safety information (DHPC)
  • Austrian Pharmacopoeia
  • Clinical trials

For Consumers

  • Medicinal products
  • Clinical trials
  • Medicines from the Internet
© 2022 Bundesamt für Sicherheit im Gesundheitswesen
keyboard_arrow_up to top

Navigation

close
  • Market Surveillance »
    • Zurück
    • Market Surveillance
    • Official announcements »
      • Zurück
      • Official announcements
      • Messages in brief
      • Human medicines
      • Veterinary medicines
      • Blood & tissue
      • Medical devices
      • Illegal market
    • Public registers »
      • Zurück
      • Public registers
      • Certified SARS-CoV-2 antigen rapid tests
      • Medicine shortages catalogue
        open_in_new
      • Catalogue according to the regulation on ensuring the provision of medicinal products
        open_in_new
      • Austrian Medicinal Product Index
        open_in_new
      • Pharmaceutical companies
      • Register of retailers
      • Internet pharmacies
        open_in_new
      • Non-interventional studies
        open_in_new
      • BASG official announcement
        open_in_new
      • BASG voting results
        open_in_new
    • Reporting »
      • Zurück
      • Reporting
      • Human adverse reaction notification
      • Veterinary Adverse Event Reports »
        • Zurück
        • Veterinary Adverse Event Reports
        • FAQ adverse events veterinary
      • Quality defects
      • Medicine shortages
      • Illegal occurrences
      • Medical devices vigilance
      • Haemovigilance
      • Tissue vigilance
      • MedSafety Week 2020
  • For Consumers »
    • Zurück
    • For Consumers
    • Facts worth knowing about medicines »
      • Zurück
      • Facts worth knowing about medicines
      • Medicinal products »
        • Zurück
        • Medicinal products
        • Classification guide for cell and tissue products
        • Generics and Biosimilars
        • Herbal medicinal products
        • Veterinary medicinal products
      • Vaccines »
        • Zurück
        • Vaccines
        • FAQ Vaccines
      • Administration of medicines
      • Package leaflet »
        • Zurück
        • Package leaflet
        • Black triangle
        • Visually impaired patients
        • Off Label Use
      • Prescription/Non-prescription requirements
      • Ability to drive
      • Medication allergies
      • Doping
      • Expiry date and storage of medicines
      • Disposal of medicinal products
      • Useful Links
    • Clinical Trials »
      • Zurück
      • Clinical Trials
      • Clinical studies and the war in Ukraine
      • EUPATI
      • Austrian information center regarding clinical trials for cancer therapy
    • Medicines from the Internet »
      • Zurück
      • Medicines from the Internet
      • Online medicine retailers »
        • Zurück
        • Online medicine retailers
        • FAQs - internet pharmacies
      • Illegal websites
    • Illegal market »
      • Zurück
      • Illegal market
      • Enforcement
      • Falsified medicines
      • "Predatory publishers" and their effect
      • Glossary
    • Medical devices
  • For Healthcare Professionals »
    • Zurück
    • For Healthcare Professionals
    • Safety information (DHPC)
    • Clinical trials »
      • Zurück
      • Clinical trials
      • Clinical trials and the war in Ukraine
      • Clinical studies and COVID-19 »
        • Zurück
        • Clinical studies and COVID-19
        • FAQ - COVID-19 studies
      • Clinial trials with medicinal products »
        • Zurück
        • Clinial trials with medicinal products
        • Recommendations for preparation for Reg (EU) 536/2014
        • Pharmacovigilance for Clinical Trials with Medicinal Products
        • EU Clinical Trials Register
      • Good Clinical Practice »
        • Zurück
        • Good Clinical Practice
        • FAQ - Documentation (GCP)
        • FAQ - Regulatory Requirements (GCP)
        • FAQ - Import of Investigational Medicinal Products
        • FAQ - Identification of Investigational Medicinal Products
        • FAQ - Handling of Investigational Medicinal Products
        • FAQ - Addictive substances as investigational drugs
      • Non-Interventional-Studies NIS »
        • Zurück
        • Non-Interventional-Studies NIS
        • FAQ
      • Compassionate use/Named Patient Use
      • Clinical investigations with medical devices »
        • Zurück
        • Clinical investigations with medical devices
        • Procedures for Clinical Trials after the Brexit
    • Blood safety »
      • Zurück
      • Blood safety
      • Authorisation and inspection of blood establishments
    • Tissue safety »
      • Zurück
      • Tissue safety
      • Certification, authorisation, and inspection of tissue establishments
    • Medical Device Operators »
      • Zurück
      • Medical Device Operators
      • FAQ's medical device operators
    • Bringing into circulation »
      • Zurück
      • Bringing into circulation
      • Supply of drugs for COVID-19 therapy
      • Dispensing of veterinary antibiotics
      • Internet pharmacy
      • Self-assessment of pharmacies
      • Sampling
    • Austrian Pharmacopoeia »
      • Zurück
      • Austrian Pharmacopoeia
      • Draft monographs for comments
      • Archive of monographs
      • Archive of deleted monographs
    • CHMP Meeting Highlights-BASG »
      • Zurück
      • CHMP Meeting Highlights-BASG
      • The CHMP introduces itself
  • For Companies »
    • Zurück
    • For Companies
    • Online services »
      • Zurück
      • Online services
      • Login online services
        open_in_new
      • Login Vigiweb
        open_in_new
      • Reporting adverse reactions
        open_in_new
      • Login NIS
        open_in_new
      • Registration online services
        open_in_new
      • Contact
      • Veterinary Antimicrobial Consumption »
        • Zurück
        • Veterinary Antimicrobial Consumption
        • Provision of data
        • Extension DDDVet, DCDVet
        • FAQ antibiotics flow
      • Data provision medicine shortages
      • Data provision Falsified Medicines Directive
      • FAQ online Service »
        • Zurück
        • FAQ online Service
        • FAQ Registration
        • FAQ User rights
        • FAQ online services
        • FAQ Notification medicine shortages
      • PHAROS user group
      • Instructions for use »
        • Zurück
        • Instructions for use
        • System requirements for electronic submission
    • Marketing authorisation & life-cycle »
      • Zurück
      • Marketing authorisation & life-cycle
      • Marketing authorisation procedure »
        • Zurück
        • Marketing authorisation procedure
        • Central Authorisation
        • MRP/DCP authorisation »
          • Zurück
          • MRP/DCP authorisation
          • Conditional Authorisation
          • Letter of Authorisation
          • MRP/DCP - national translations
          • Withdrawal during the authorisation procedure
        • National Authorisation
        • Line Extension
        • Utilisation of genetic resources and traditional knowledge associated with genetic resources
        • Parallel import
        • Accessible patient information leaflet
        • Safety features AMVS
        • Classification and supply of substances under control »
          • Zurück
          • Classification and supply of substances under control
          • Prescription of medicines
      • Austria as RMS »
        • Zurück
        • Austria as RMS
        • DCP/MRP/RUP Slots
        • RMS transfer
        • RMS NEWS
      • Electronic application
      • AGES eValidator
      • FAQ electronic Submission
      • Life-Cycle
      • Commission decisions
      • Forms for medicinal products »
        • Zurück
        • Forms for medicinal products
        • National authorisation Life-Cycle forms
      • Change of ownership acc. to Art 25 AMG
      • Veterinary medicinal products »
        • Zurück
        • Veterinary medicinal products
        • Austria as RMS
          open_in_new
        • The new EU veterinary medicinal products regulation »
          • Zurück
          • The new EU veterinary medicinal products regulation
          • European guidelines
          • Implementation status in Austria
          • Application for Marketing Authorisation and Variations
          • Implementation of new QRD templates
          • SPC harmonisation of veterinary medicinal products
          • Clinical trials
          • Pharmacovigilance
          • Union Product Database (UPD) »
            • Zurück
            • Union Product Database (UPD)
            • Nomenclature of the texts
            • Organization Management Service (OMS)
        • Antimicrobial Consumption
          open_in_new
        • Contact
      • FAQ marketing authorisation & life-cycle »
        • Zurück
        • FAQ marketing authorisation & life-cycle
        • Application for variation »
          • Zurück
          • Application for variation
          • Variations to MRP and DCP authorisations
          • Variations to national authorisations
          • Approval Letter following Variation
          • End of Procedure date in case of Type IA/IAin Variations
        • Austrian Medicinal Product Index
        • ASMF
        • Decisions - electronic delivery
        • Braille writing system
        • Batch release
        • Anti-doping warning
        • Elemental Impurities - ICHQ3D
        • Environmental Risk Assessment - ERA
        • SmPC and PL
        • Accessible patient information leaflet
        • Homeopathic Medicinal Products
        • Annual fee
        • Medicines for children/Paediatric Worksharing
        • Mock-ups
        • Naming of medicinal products
        • Parallelimport
        • Herbal Medicinal Products
        • Black Triangle
        • Sunset clause
        • Renewal of marketing authorisation
        • Distributor in Austria
        • Authorisation/registration applications
    • Pharmacovigilance »
      • Zurück
      • Pharmacovigilance
      • Pharmacovigilance inspection
      • PHV-wordings
      • Submission of Periodic Safety Update Reports (PSURs)
      • FAQ pharmacovigilance
      • Guideline pharmacovigilance
    • Medicinal products »
      • Zurück
      • Medicinal products
      • Scientific advice by BASG
      • Quality of medicines
      • Medicines for children
      • Plasma derived products
      • Batch release
      • Recombinant proteins
      • Addictive drugs »
        • Zurück
        • Addictive drugs
        • Forms
        • FAQ Suchtmittel
      • Radiopharmaceuticals
    • Import and export of medicines »
      • Zurück
      • Import and export of medicines
      • Import of medicines
      • FAQ Import of medicinal products
      • Certificate for a Pharmaceutical Product (CPP)
    • Medical devices »
      • Zurück
      • Medical devices
      • COVID 19
      • Manufacturer
      • Importer
      • Medical devices fee
      • Free Sale Certificate - (FSC)
      • MDR / IVDR
    • Authorisation and certification »
      • Zurück
      • Authorisation and certification
      • GMP/ GDP »
        • Zurück
        • GMP/ GDP
        • FAQ - GMP/GDP
        • FAQ - reportable qualified persons
        • FAQ - human plasma for fractionation
        • FAQ - enforcement
      • Good Laboratory Practice (GLP) »
        • Zurück
        • Good Laboratory Practice (GLP)
        • FAQ - GLP
      • IT inspections »
        • Zurück
        • IT inspections
        • FAQ - CAS
    • Borderline products »
      • Zurück
      • Borderline products
      • Decisions of the AGBR
  • About us »
    • Zurück
    • About us
    • Vision, values and strategy
    • Activities
    • Legal basis »
      • Zurück
      • Legal basis
      • Legal ordinances of BASG
    • BASG publications »
      • Zurück
      • BASG publications
      • BASG approval procedure »
        • Zurück
        • BASG approval procedure
        • BASG Protocols
      • BASG announcements
      • Rules of Procedure (in German only)
    • Fees »
      • Zurück
      • Fees
      • Official announcements
    • Quality Management
    • European Network
    • Scientific Board
    • Statistics »
      • Zurück
      • Statistics
      • Reports COVID-19 Vaccination
      • Statistics on reporting
    • Publications »
      • Zurück
      • Publications
      • Annual Reports
      • Folder
      • Scientific Publications
    • Official electronic signature
    • Press »
      • Zurück
      • Press
      • Photos
  • Events
    open_in_new
  • How to contact us
  • What's new »
    • Zurück
    • What's new
    • Registration and cancellation
    • RSS
  • Accessibility »
    • Zurück
    • Accessibility
    • Accessibility of the online form for reporting of suspected adverse reactions (vaccines/medicines)
  • Legal notice
  • Privacy notice